HCG Hospitals

Ahmedabad, India Founded: 2003 • Age: 23 yrs Listed
A diversified provider of healthcare services and facilities.
Request Access
Report Incorrect Data
Page last updated

About HCG Hospitals

HCG Hospitals is a publicly listed company based in Ahmedabad (India) founded in 2003. A diversified provider of healthcare services and facilities. It operates on a B2C model. Its website hcghospitals.in draws about 27 thousand monthly visits. Its Indian entity Healthcare Global Enterprises Limited reported revenue of ₹2,572 Cr. Its focus areas include Medical Services, Hospitals and General Healthcare. Similar companies include Narayana Health, Fortis Healthcare and Apollo Hospitals; 1 of its 3 listed similar companies has raised funding.

Company details

HCG Hospitals, established in 2003, excels in providing healthcare solutions, medical services, hospitals, and general healthcare. A diversified provider of healthcare services and facilities. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

Operational Areas
Healthcare → Hospitals & Clinical Care
Key Metrics
  • Market Cap
    ₹8,221 Cr

    HCG · NSE

  • Share Price
    ₹549.65

    -0.18% today

  • Revenue
    ₹2,538 Cr

    FY 2025-26 · +14.4% YoY

  • EBITDA
    ₹414 Cr

    Margin 16.3%

  • Net Profit
    ₹38.32 Cr

    FY 2025-26 · -14.7% YoY

  • P/E (TTM)
    130.5x

    P/B 6.2x

  • ROE
    3.0%

    ROCE 7.2%

  • Debt / Equity
    1.58

    Interest cover 103.8x

Apps and channels of HCG Hospitals

its YouTube channel HCG Multispeciality Hospitals has 3.23K subscribers and 30 videos.

HCG Multispeciality Hospitals
YouTube 3.23K subscribers 30 videos Howto & Style
Open channel

Videos from HCG Hospitals

The most watched videos on HCG Hospitals's YouTube channel, HCG Multispeciality Hospitals (3.23K subscribers). Click a video to play it here.

Cancer Treatment | Cancer Awareness | HCG Hospitals
345 views
Patient recovery | Neurology Expert | HCG Hospitals
331 views
Cancer Treatment | Cancer Awareness | HCG Hospitals
330 views
When pain made everyday life difficult, Sarojben chose courage — and expert care | HCG Hospitals
220 views

More on HCG Multispeciality Hospitals.

Board of directors of Healthcare Global Enterprises Limited (HCG Hospitals)

Healthcare Global Enterprises Limited is the primary company behind HCG Hospitals. The boards of the 2 registered companies of HCG Hospitals currently have 15 directors; the longest-serving is Basavalinga Ajaikumar Sadasivaiah, appointed in 2007. 53 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Basavalinga Ajaikumar Sadasivaiah
DIN 00713779
Director19 Jul 200719 yrs 3 moHcg Medi-Surge Hospitals Private Limited, Healthcare Global Enterprises Limited
Ramesh S Bilimagga
DIN 00518434
Director14 Sep 200917 yrs 1 moHcg Medi-Surge Hospitals Private Limited
Rajendra Bhagwandas Toprani
DIN 01576097
Director08 Sep 201610 yrs 1 moHcg Medi-Surge Hospitals Private Limited
Srinivasa Venkatavaradhan Raghavan
DIN 01803376
Director30 Jul 20206 yrs 2 moHcg Medi-Surge Hospitals Private Limited
Anjali Rossi Ajaikumar
DIN 08057112
Director01 Apr 20215 yrs 6 moHealthcare Global Enterprises Limited
Geeta Mathur
DIN 02139552
Director17 Jun 20215 yrs 4 moHealthcare Global Enterprises Limited
Rajagopalan Raghavan
DIN 03627923
Director12 Aug 20215 yrs 2 moHealthcare Global Enterprises Limited
Pradip Manilal Kanakia
DIN 00770347
Director10 Feb 20224 yrs 8 moHealthcare Global Enterprises Limited
Rajiv Maliwal
DIN 00869035
Director25 May 20233 yrs 5 moHealthcare Global Enterprises Limited
Kaustubhbhai Dhirajlal Patel
DIN 00416488
Director02 Aug 20242 yrs 2 moHcg Medi-Surge Hospitals Private Limited
Akshay Tanna
DIN 02967021
Director30 May 20251 yr 4 moHealthcare Global Enterprises Limited
Simrun Mehta
DIN 09118938
Director30 May 20251 yr 4 moHealthcare Global Enterprises Limited
Manish Mattoo
DIN 08431924
Whole-time director30 Jun 20251 yr 3 moHealthcare Global Enterprises Limited
Bijou Kurien
DIN 01802995
Director30 Jun 20251 yr 3 moHealthcare Global Enterprises Limited
Vijay Govinda Devanhalli
DIN 01576126
Additional Director08 Dec 202510 moHcg Medi-Surge Hospitals Private Limited

People of HCG Hospitals

8 people are tracked at HCG Hospitals (7 in leadership, 1 in team).

NameRoleGroup
Bharat Gadhavi
CEOLeadership
Parth Patel
Head Of DepartmentLeadership
Jitesh Rawat
Associate General ManagerLeadership
Heli Bhagat
Regional Head Branding & CommunicationLeadership
Ca Ishita Hariyani
Head Of DepartmentLeadership
Dr. Nitin Sharma
Head And Neck SurgeonLeadership
Rajesh Shah
Billing Manager (head Billing)Leadership
Mrunali Ghadge
BTL MarketingTeam
Premium access

Complete people profiles for HCG Hospitals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of HCG Hospitals

HCG Hospitals is a publicly listed company on the NSE with ticker symbol HCG in India, operating in the Healthcare sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: HCG
  • Listed entityHealthcare Global Enterprises Limited
  • Exchange sectorHealthcare

Financials of HCG Hospitals

Exchange-reported figures of Healthcare Global Enterprises Limited, the listed company behind HCG Hospitals (NSE: HCG).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹2,538 Cr
+14.4% YoY
EBITDA
₹414 Cr
+8.3% YoY
Profit After Tax
₹38.32 Cr
-14.7% YoY
Net Worth
₹1,332 Cr
+44.4% YoY
Total Assets
₹3,279 Cr
+11.1% YoY
Total Debt
₹1,735 Cr
-5.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue2,5382,2181,9081,6911,3951,0091,092
Revenue growth+14.4%+16.3%+12.8%+21.3%+38.2%-7.6%-
EBITDA41438332529617822.73157
EBITDA margin+16.3%+17.3%+17.1%+17.5%+12.8%+2.3%+14.3%
Profit before tax26.9156.9667.7144.8787.76(229)(119)
Net profit38.3244.9447.0829.868.60(102)(107)
Net profit margin+1.5%+2.0%+2.5%+1.8%+0.6%-10.1%-9.8%
EPS (₹)0.923.193.462.113.87(15.43)(12.03)
Balance sheet
Total assets3,2792,9512,1881,8201,8341,7281,878
Net worth1,332922826861870697381
Total debt1,7351,8371,2749019159771,347
Cash & bank54134830319719840.8532.02
Net working capital49425516696.42118132(64.17)
Cash flow
Cash from operations347317285252220121130
Cash from investing(177)(488)(226)(133)125(171)(101)
Cash from financing241(42.44)(64.02)(140)(155)112(58.43)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue695652633647613585559554
Revenue growth (YoY)+13.4%+11.5%+13.3%+16.9%+16.7%---
Other income13.0613.592.472.937.5110.235.5411.13
EBITDA12293.1796.8912310810688.38102
EBITDA margin+17.6%+14.3%+15.4%+19.1%+17.6%+18.1%+15.9%+18.5%
Depreciation70.4262.8160.6562.8057.9158.0756.5249.74
Interest39.8742.7044.7843.6245.4744.1740.7035.98
Profit before tax25.031.25(6.07)19.8211.9213.62(3.30)27.65
Tax8.57(2.79)1.83(0.84)5.946.85(11.05)6.97
Net profit16.464.04(7.90)20.665.986.777.7520.68
EPS (₹)0.920.15(0.68)1.160.340.520.491.28
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,3591,2771,1711,006850609688
Revenue growth+6.5%+9.0%+16.4%+18.3%+39.6%-11.6%-
EBITDA18017718117470.35(85.41)84.83
EBITDA margin+13.3%+13.8%+15.4%+17.3%+8.3%-14.0%+12.3%
Profit before tax9.6119.5853.7057.6281.03(205)(65.46)
Net profit65.7817.6941.1543.1113.30(38.39)(22.47)
Net profit margin+4.8%+1.4%+3.5%+4.3%+1.6%-6.3%-3.3%
EPS (₹)0.980.252.352.892.75(15.28)(6.01)
Balance sheet
Total assets2,6852,3661,9811,5341,4781,4371,476
Net worth1,6051,1911,1811,1451,098924615
Total debt1,0221,118758347349481827
Cash & bank47426423780.3712014.4615.14
Net working capital650408281187190190(52.39)
Cash flow
Cash from operations16014620913012470.8986.34
Cash from investing(75.82)(347)(254)(138)48.65(246)(116)
Cash from financing336(41.55)95.92(41.71)(41.04)236(2.76)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue377350342346327324313329
Revenue growth (YoY)+15.2%+8.0%+9.5%+5.0%+11.4%---
Other income9.5614.922.993.827.949.465.299.79
Total expenses317323296284277265305268
EBITDA59.2227.6246.4462.3049.8558.897.5061.58
EBITDA margin+15.8%+7.9%+13.6%+18.1%+15.3%+18.2%+2.4%+18.7%
Depreciation39.5731.3030.0930.1628.2529.0527.9027.88
Interest21.7320.1920.6121.3624.3022.5021.2720.58
Profit before tax7.48(8.95)(1.27)14.605.2416.80(36.38)22.91
Tax1.90(10.48)(0.09)3.821.796.650.954.96

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 23 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue695652633647613585559554
Revenue growth (YoY)+13.4%+11.5%+13.3%+16.9%+16.7%---
Other income13.0613.592.472.937.5110.235.5411.13
EBITDA12293.1796.8912310810688.38102
EBITDA margin+17.6%+14.3%+15.4%+19.1%+17.6%+18.1%+15.9%+18.5%
Depreciation70.4262.8160.6562.8057.9158.0756.5249.74
Interest39.8742.7044.7843.6245.4744.1740.7035.98
Profit before tax25.031.25(6.07)19.8211.9213.62(3.30)27.65
Tax8.57(2.79)1.83(0.84)5.946.85(11.05)6.97
Net profit16.464.04(7.90)20.665.986.777.7520.68
EPS (₹)0.920.15(0.68)1.160.340.520.491.28
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue2,5382,2181,9081,6911,3951,0091,092
Revenue growth+14.4%+16.3%+12.8%+21.3%+38.2%-7.6%-
Other income33.4340.3025.4816.2216626.9810.27
Total expenses2,1241,8361,5831,3961,217986936
Employee cost379353308275234196208
EBITDA41438332529617822.73157
EBITDA margin+16.3%+17.3%+17.1%+17.5%+12.8%+2.3%+14.3%
Depreciation244211174163158159148
Interest17715510910497.77119138
Profit before tax26.9156.9667.7144.8787.76(229)(119)
Tax4.148.1326.4027.2548.85(7.56)6.19
Net profit38.3244.9447.0829.868.60(102)(107)
Net profit margin+1.5%+2.0%+2.5%+1.8%+0.6%-10.1%-9.8%
EPS (₹)0.923.193.462.113.87(15.43)(12.03)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital14913913913913912588.69
Reserves & surplus1,183783686721731528293
Shareholders' funds (net worth)1,332922826861870697381
Minority interest78.2467.6139.348.8913.4316.8238.51
Secured loans879962639376371421688
Unsecured loans856875636525544556658
Total debt1,7351,8371,2749019159771,347
Total liabilities3,2792,9512,1881,8201,8341,7281,878
Assets
Gross block3,8023,6162,7812,4192,2551,9332,025
Net block2,4622,4421,7581,5531,5471,3821,646
Capital work in progress18.5724.7683.1818.1821.7330.0146.09
Investments13.8811.3110.339.698.8226.2834.12
Inventories59.8253.0242.6738.2929.9721.1123.26
Sundry debtors421401294303217187186
Cash & bank balances54134830319719840.8532.02
Loans & advances11442.1840.0842.9057.4118662.85
Total current assets1,135844680580502435304
Total current liabilities641589513484384303368
Net working capital49425516696.42118132(64.17)
Total assets3,2792,9512,1881,8201,8341,7281,878
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash(47.06)1661711932.87(58.79)(29.12)
Net cash from operating activities347317285252220121130
Net cash from investing activities(177)(488)(226)(133)125(171)(101)
Net cash from financing activities241(42.44)(64.02)(140)(155)112(58.43)
Net change in cash410(213)(5.16)(21.51)19061.66(29.67)
Closing cash54134830319719840.8532.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+14.4%+16.3%+12.8%+21.3%+38.2%-7.6%-
EBITDA growth+8.3%+17.6%+10.1%+65.9%+684.1%-85.5%-
PBT growth-52.8%-15.9%+50.9%-48.9%+9998.0%-91.8%-257.2%
Net income growth-14.7%-4.6%+57.7%+247.2%+108.4%+4.5%-
Revenue CAGR (3Y)+14.5%+16.7%+23.7%+15.7%+12.6%+6.8%+16.0%
EBITDA CAGR (3Y)+11.9%+29.0%+142.8%+23.6%+16.9%-40.5%+14.3%
Profitability & leverage
Net income margin+0.9%+2.2%+2.2%+1.0%+2.8%-21.9%-11.5%
Return on capital employed+7.2%+7.1%+7.2%+6.6%+4.6%0.0%0.0%
Return on net worth+3.1%+3.7%+3.1%+1.4%-0.6%0.0%0.0%
Debt / equity1.581.781.291.051.212.162.34
Long-term debt / equity1.211.391.100.951.051.811.93
Interest cover103.8390.2772.0378.32490.08-87.311,695.20
Efficiency & per share
Fixed asset turnover0.680.690.730.720.670.510.68
Inventory turnover44.9946.3647.1349.5654.6145.4943.67
Debtors turnover6.186.386.406.516.905.426.38
EPS (₹)0.923.193.462.113.87(15.43)(12.03)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)89.2166.1659.2861.8662.6152.1142.99
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue377350342346327324313329
Revenue growth (YoY)+15.2%+8.0%+9.5%+5.0%+11.4%---
Other income9.5614.922.993.827.949.465.299.79
Total expenses317323296284277265305268
EBITDA59.2227.6246.4462.3049.8558.897.5061.58
EBITDA margin+15.8%+7.9%+13.6%+18.1%+15.3%+18.2%+2.4%+18.7%
Depreciation39.5731.3030.0930.1628.2529.0527.9027.88
Interest21.7320.1920.6121.3624.3022.5021.2720.58
Profit before tax7.48(8.95)(1.27)14.605.2416.80(36.38)22.91
Tax1.90(10.48)(0.09)3.821.796.650.954.96
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,3591,2771,1711,006850609688
Revenue growth+6.5%+9.0%+16.4%+18.3%+39.6%-11.6%-
Other income35.6038.5820.1014.5514229.7912.11
Total expenses1,1791,100990832779694604
Employee cost212221205175157137143
EBITDA18017718117470.35(85.41)84.83
EBITDA margin+13.3%+13.8%+15.4%+17.3%+8.3%-14.0%+12.3%
Depreciation12011196.9288.9788.3686.5879.41
Interest86.4684.1450.0741.4942.8062.8682.99
Profit before tax9.6119.5853.7057.6281.03(205)(65.46)
Tax(4.96)16.0520.9017.4342.79(13.51)(12.16)
Net profit65.7817.6941.1543.1113.30(38.39)(22.47)
Net profit margin+4.8%+1.4%+3.5%+4.3%+1.6%-6.3%-3.3%
EPS (₹)0.980.252.352.892.75(15.28)(6.01)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital14913913913913912588.69
Reserves & surplus1,4551,0521,0421,006959755526
Shareholders' funds (net worth)1,6051,1911,1811,1451,098924615
Secured loans54762239711283.42204398
Unsecured loans475495361235266278429
Total debt1,0221,118758347349481827
Total liabilities2,6852,3661,9811,5341,4781,4371,476
Assets
Gross block1,9041,6991,5661,2751,1771,0581,141
Net block1,1221,038974788774745914
Capital work in progress13.7922.6136.499.224.8227.6143.61
Investments704696506475439366316
Inventories25.2419.7623.2221.2217.3011.9512.51
Sundry debtors262262221212160147152
Cash & bank balances47426423780.3712014.4615.14
Loans & advances12094.5750.4558.5658.6515460.62
Total current assets882640532373356328241
Total current liabilities232232250186166138293
Net working capital650408281187190190(52.39)
Total assets2,6852,3661,9811,5341,4781,4371,476
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash(122)12170.31119(12.68)(73.86)(41.45)
Net cash from operating activities16014620913012470.8986.34
Net cash from investing activities(75.82)(347)(254)(138)48.65(246)(116)
Net cash from financing activities336(41.55)95.92(41.71)(41.04)236(2.76)
Net change in cash421(243)50.87(49.02)13261.19(32.41)
Closing cash47426423780.3712014.4615.14
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+6.5%+9.0%+16.4%+18.3%+39.6%-11.6%-
EBITDA growth+2.1%-2.3%+4.1%+146.7%+182.4%-200.7%-
PBT growth-50.9%-63.5%-6.8%-28.9%+9998.0%-213.3%-
Net income growth+271.9%-57.0%-4.6%+224.1%+134.6%-70.9%-
Revenue CAGR (3Y)+10.6%+14.5%+24.4%+13.5%+9.9%+1.3%+8.1%
EBITDA CAGR (3Y)+1.3%+35.9%-+26.9%-9.2%-+0.9%
Profitability & leverage
Net income margin+1.1%+0.3%+2.8%+4.0%+4.5%-31.5%-7.7%
Return on capital employed+5.7%+6.0%+6.3%+5.9%+4.6%0.0%0.0%
Return on net worth+4.3%+1.3%+3.1%+3.1%+1.2%0.0%0.0%
Debt / equity0.770.790.480.310.410.850.99
Long-term debt / equity0.520.560.390.270.330.660.79
Interest cover142.98129.1759.8449.07-237.65-36.551,531.18
Efficiency & per share
Fixed asset turnover0.750.780.820.820.760.550.75
Inventory turnover60.4259.4052.6852.2158.1149.7847.72
Debtors turnover5.195.295.415.405.524.064.62
EPS (₹)0.980.252.352.892.75(15.28)(6.01)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)107.4985.4584.8282.3178.9670.1969.29

Similar companies to HCG Hospitals

HCG Hospitals has 3 listed similar companies in our database, 1 of them funded. They include Narayana Health, Fortis Healthcare and Apollo Hospitals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Narayana Health
narayanahealth.org2000Bengaluru, India$148.2M8,145
A chain of multi-specialty hospitals is operated in India.
Fortis Healthcare
fortishealthcare.com1996Gurugram, India1,565
Multi-specialty hospital services are provided across India by Fortis Healthcare.
Apollo Hospitals
apollohospitals.com1983Chennai, India21,350
Chain of multispecialty hospitals
Premium access

Detailed similar companies of HCG Hospitals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of HCG Hospitals

The website of HCG Hospitals (hcghospitals.in) receives about 27.3K visits a month.

  • Monthly visits
    27.3K

    ▲ 20.1% vs previous month

Similar websites

Websites whose visitors overlap most with HCG Hospitals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
HCG
hcgoncology.com
100%
86.8K#439,166View details
Sterling Hospitals
sterlinghospitals.com
91%
16K#1,587,437View details
Shalby Hospitals
shalby.org
89%
36K#929,367View details
CIMS Hospital
cims.org
89%
25.6K#1,196,851View details
Zydus Hospitals
zydushospitals.com
86%
65.2K#508,541View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 16 similar websites and full traffic analytics for HCG Hospitals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Hospitals & Clinical Care

3 companies that operate in the same segment as HCG Hospitals (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cloudnine
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M4,459
HCG
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 36.59 MUSD 270.51 M8,400
Medanta
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hcg Hospitals

Buy HealthCare Global Enterprises; target of Rs 820: Prabhudas Lilladher
Moneycontrol • 19 days ago
HCG Aastha Cancer Centre Launches Advanced PET-CT, Gamma Camera, and Targeted Therapies
The Tribune • 25 days ago
Medicover India hospitals to be profitable in 18 months, eyes 20-25% margins
Reuters • 1 month ago
HCG CEO Manish Mattoo sees margin expansion, acquisitions driving next leg of growth
Moneycontrol • 2 months ago
Buy HealthCare Global Enterprises; target of Rs 800: ICICI Securities
Moneycontrol • 2 months ago
Buy HealthCare Global Enterprises; target of Rs 820: Prabhudas Lilladher
Moneycontrol • 2 months ago
HCG: Revenue up 13% YoY, adjusted EBITDA margin at 19.4%, with strong growth and margin expansion
Quartr • 2 months ago
HCG: Revenue and net profit rose year-over-year, with key divestment and acquisition completed
Quartr • 2 months ago
HCG: Q1 FY27 saw 13% revenue growth, 20% higher adjusted EBITDA, and 190% PAT surge, driven by oncology focus
Quartr • 2 months ago
Healthcare Global Enterprises Limited June-Quarter Consol Net Profit 137.7 Million Rupees
Reuters • 2 months ago
Premium access

Complete news archive for HCG Hospitals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about HCG Hospitals

HCG Hospitals was founded in 2003.

HCG Hospitals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

The primary company behind HCG Hospitals, Healthcare Global Enterprises Limited, reported revenue of ₹2,572 Cr for FY 2026, up 14% year on year.

HCG Hospitals, established in 2003, excels in providing healthcare solutions, medical services, hospitals, and general healthcare. A diversified provider of healthcare services and facilities. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

HCG Hospitals's top competitors include Fortis Healthcare, Apollo Hospitals and Narayana Health.

Yes, HCG Hospitals is publicly traded on NSE under the ticker symbol HCG.

HCG Hospitals is associated with 2 legal entities: Healthcare Global Enterprises Limited, Hcg Medi-Surge Hospitals Private Limited.

The legal entities of HCG Hospitals currently have 17 directors, including Ramesh S Bilimagga, Vijay Govinda Devanhalli, Rajendra Bhagwandas Toprani and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available